Drug addiction treatment developed by UAB researchers included in national registry

Being included in this registry means the treatment has been codified as a best practice.

The U.S. Department of Health and Human Services (HHS) has included a treatment for drug addiction developed by Joseph E. Schumacher, Ph.D., professor in the Division of Preventive Medicine in the University of Alabama at Birmingham (UAB)  School of Medicine and Jesse B. Milby, Ph.D., professor emeritus in the Department of Psychology in the College of Arts and Sciences, in its National Registry of Evidence Based Programs and Practices.

Their treatment, “Behavioral Day Treatment and Contingency Managed Housing and Work Therapy,” is a program for adults who are homeless and have co-occurring substance use and nonpsychotic mental disorders. Based on therapeutic goals management, the treatment helps participants to stop using substances through support and contingencies, and it provides them with housing and work therapy.

Being included in this registry means the treatment has been codified as a best practice, has passed rigorous peer critique, is now easily accessible to social and clinical service agencies for implementation and meets the criteria for an evidence-based practice required for HHS research, evaluation, and grant funding.

Innovation & Development

 
 
Back to Top